Based on interviews, and record reviews, the facility failed to ensure transportation was provided for a scheduled oncology (the study and treatment of tumors) appointment for 1 (R #94) of 1 (R #94) resident reviewed. This failure resulted in the resident missing a prescribed chemotherapy treatment, potentially impacting the resident's health outcomes.The findings are:A. Record review of R #94's face sheet revealed he was admitted to the facility on [DATE] with the following diagnoses (including but not limited to):1. Malignant neoplasm of colon, unspecified (also known as colon cancer, cancer that forms in the tissues of the colon).2. Secondary malignant to neoplasm of liver and intrahepatic bile duct (cancers that arise in the liver or the bile ducts within the liver).3. …
F774 citations in New Mexico
Administration Deficiencies
Help the resident with transportation to and from laboratory services outside of the facility.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2023
New Mexico cites F774 more often than its own record predicts
12.43 times the share F774 takes of citations nationally.
Of every deficiency written in New Mexico in 2023, this is the portion that was F774.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New Mexico surveyors wrote
F774 findings written in New Mexico, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else New Mexico surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction